A new study has found that an RNA-binding protein called TDP-43 could be a promising new biomarker for diagnosing amyotropic lateral sclerosis.
FDA Clears IND Application for Myogenica’s MyoPAXon in Muscular Dystrophy
Special Episode: FDA Approves Donanemab for Early Symptomatic Alzheimer Disease
Subcutaneous Immunoglobulin Shows Superiority Over IVIG in Treating CIDP, Meta-Analysis Shows
Episode 116: Understanding Vorasidenib's Therapeutic Benefit on Neurocognition, Seizure Control in Diffuse Gliomas
Amifampridine in LEMS and Beyond: Unraveling Its Therapeutic Potential
NeurologyLive® Brain Games: July 21, 2024